MedTrace Logo

Hub Cleansing to Prevent Hub Infection

NCT01563406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2016-04-18

Study results available
· View outcomes & findings →

Summary

Central venous catheter infections are common preventable adverse events among hospital patients. Microbes may enter catheter hubs, also known as needleless connectors, and result in downstream contamination. This study aims to compare alcohol disinfection of catheter hubs to disinfection with chlorhexidine gluconate in alcohol, which has been proven to be a superior disinfectant at the site of central venous catheter insertion. Scrub duration of central venous catheter hubs will also be evaluated.

Conditions

  • Bacteremia

Interventions

OTHER

15 second scrub

Scrub catheter hubs for 15 seconds before every access.

OTHER

5 second scrub

Scrub catheter hubs for 15 seconds before every access.

DRUG

3.15% chlorhexidine/70% isopropyl alcohol

3.15% chlorhexidine gluconate in 70% isopropyl alcohol pads will be used to disinfect catheter hubs prior to accessing central venous catheters during half of the study period.

DRUG

70% isopropyl alcohol

70% isopropyl alcohol pads will be used to disinfect catheter hubs prior to accessing central venous catheters for the other half of the study period.

Sponsors & Collaborators

Principal Investigators

  • Mary K Hayden, MD · Rush University Medical Center

  • Robert A Weinstein, MD · Cook County Health and Hospital Systems

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01563406 on ClinicalTrials.gov